BPC 157: Miracle Healing Peptide or Hidden Danger? FDA Targets GLP 1 and Peptide Compounding, Advertising and 'Research Use Only' Labeling In a major policy shift, the U.S. Food and Drug Administration is reconsidering restrictions on several controversial peptides, including trending compounds like BPC 157 and Melanotan II. The move comes as demand for Peptides, Drugs And Supplements: Science, Risks, And Alternatives Los Angeles Times The FDA has issued clear signals on BPC 157: it is not approved for human use in any form due to potential significant safety risks. This critical classification profoundly impacts research and BPC 157 And TB 500: Background, Indications, Efficacy, And Safety GlobalRPH